Evidence map›Paper›PMID 29886846›Full record

Trial reportBMC medicine2018

Avoidable waste of research related to outcome planning and reporting in clinical trials.

Youri Yordanov, Agnes Dechartres, Ignacio Atal, Viet-Thi Tran, Isabelle Boutron, Perrine Crequit, Philippe Ravaud

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Telehealth palliative care interventions for patients with advanced cancer: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Articulating the "So, What?" in Clinical Research: Insight from the M-CHOIR Group.Plastic and reconstructive surgery. Global open · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Youri YordanovINSERM, U1153, Hôpital Hôtel-Dieus, 1, place du parvis Notre Dame, 75004, Paris, France. youri.yordanov@aphp.fr.ORCID 0000-0003-0671-6547
Agnes DechartresINSERM, U1153, Hôpital Hôtel-Dieus, 1, place du parvis Notre Dame, 75004, Paris, France.
Ignacio AtalINSERM, U1153, Hôpital Hôtel-Dieus, 1, place du parvis Notre Dame, 75004, Paris, France.
Viet-Thi TranINSERM, U1153, Hôpital Hôtel-Dieus, 1, place du parvis Notre Dame, 75004, Paris, France.
Isabelle BoutronINSERM, U1153, Hôpital Hôtel-Dieus, 1, place du parvis Notre Dame, 75004, Paris, France.
Perrine CrequitINSERM, U1153, Hôpital Hôtel-Dieus, 1, place du parvis Notre Dame, 75004, Paris, France.
Philippe RavaudINSERM, U1153, Hôpital Hôtel-Dieus, 1, place du parvis Notre Dame, 75004, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInadequate planning, selective reporting, and incomplete reporting of outcomes in randomized controlled trials (RCTs) contribute to the problem of waste of research. We aimed to describe such a waste and to examine to what extent this waste could be avoided.

methodsThis research-on-research study was based on RCTs included in Cochrane reviews with a summary of findings (SoF) table. We considered the outcomes reported in the SoF tables as surrogates for important outcomes for patients and other decision makers. We used a three-step approach. (1) First, in each review, we identified, for each important outcome, RCTs that were excluded from the corresponding meta-analysis. (2) Then, for these RCTs, we systematically searched for registrations and protocols to distinguish between inadequate planning (an important outcome was not reported in registries or protocols), selective reporting (an important outcome was reported in registries or protocols but not in publications), and incomplete reporting (an important outcome was incompletely reported in publications). (3) Finally, we assessed, with the consensus of five experts, the feasibility and cost of measuring the important outcomes that were not planned. We considered inadequately planned or selectively or incompletely reported important outcomes as avoidable waste if the outcome could have been easily measured at no additional cost based on expert evaluation.

resultsOf the 2711 RCTs included in the main comparison of 290 reviews, 2115 (78%) were excluded from at least one meta-analysis of important outcomes. Every trial contributed to 55%, on average, of the meta-analyses of important outcomes. Of the 310 RCTs published in 2010 or later, 156 were registered. Inadequate planning affected 79% of these RCTs, whereas incomplete and selective reporting affected 41% and 15%, respectively. For 63% of RCTs, we found at least one missing important outcome for which the waste was avoidable and for 30%, the waste was avoidable for all important outcomes.

conclusionsMost of the RCTs included in our sample did not contribute to all the important outcomes in meta-analyses, mostly because of inadequate planning or incomplete reporting. A large part of this waste of research seemed to be avoidable.

Indexed as

Clinical Trials as TopicHumansResearch ReportTreatment OutcomeCore outcome setOutcomeRandomized controlled trialSelective reportingWaste of research

Identifiers

PMID29886846
PMCPMC5994653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.